Arrowstreet Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $151M | Buy |
1,890,859
+1,462,238
| +341% | +$121M | 0.08% | 233 |
|
|
2025
Q4 | $36.5M | Buy |
428,621
+146,651
| +52% | +$12M | 0.02% | 563 |
|
|
2025
Q3 | $21.9M | Buy |
281,970
+128,096
| +83% | +$10M | 0.01% | 699 |
|
|
2025
Q2 | $12M | Sell |
153,874
-112,182
| -42% | -$8.37M | 0.01% | 846 |
|
|
2025
Q1 | $19.3M | Buy |
266,056
+220,068
| +479% | +$15.8M | 0.02% | 604 |
|
|
2024
Q4 | $3.4M | Sell |
45,988
-43,796
| -49% | -$3.07M | ﹤0.01% | 1125 |
|
|
2024
Q3 | $5.92M | Sell |
89,784
-135,236
| -60% | -$9.83M | 0.01% | 916 |
|
|
2024
Q2 | $20.8M | Sell |
225,020
-631,986
| -74% | -$56M | 0.02% | 470 |
|
|
2024
Q1 | $81.9M | Sell |
857,006
-204,778
| -19% | -$17.2M | 0.08% | 225 |
|
|
2023
Q4 | $81M | Sell |
1,061,784
-389,815
| -27% | -$27.1M | 0.08% | 200 |
|
|
2023
Q3 | $101M | Sell |
1,451,599
-652,500
| -31% | -$52.4M | 0.12% | 156 |
|
|
2023
Q2 | $198M | Sell |
2,104,099
-4,274
| -0.2% | -$371K | 0.24% | 101 |
|
|
2023
Q1 | $174M | Sell |
2,108,373
-620,906
| -23% | -$48.8M | 0.23% | 118 |
|
|
2022
Q4 | $204M | Buy |
2,729,279
+298,351
| +12% | +$23M | 0.28% | 101 |
|
|
2022
Q3 | $201M | Sell |
2,430,928
-365,613
| -13% | -$35.2M | 0.3% | 96 |
|
|
2022
Q2 | $266M | Sell |
2,796,541
-515,592
| -16% | -$53.4M | 0.38% | 65 |
|
|
2022
Q1 | $390M | Buy |
3,312,133
+51,140
| +2% | +$5.74M | 0.49% | 49 |
|
|
2021
Q4 | $422M | Buy |
3,260,993
+708,921
| +28% | +$82.7M | 0.52% | 42 |
|
|
2021
Q3 | $289M | Buy |
2,552,072
+1,074,538
| +73% | +$123M | 0.36% | 55 |
|
|
2021
Q2 | $153M | Buy |
1,477,534
+512,265
| +53% | +$48.3M | 0.19% | 116 |
|
|
2021
Q1 | $80.7M | Buy |
965,269
+941,850
| +4,022% | +$79.6M | 0.11% | 189 |
|
|
2020
Q4 | $2.14M | Sell |
23,419
-242,661
| -91% | -$20.1M | ﹤0.01% | 1571 |
|
|
2020
Q3 | $21.2M | Sell |
266,080
-1,572,792
| -86% | -$123M | 0.03% | 535 |
|
|
2020
Q2 | $127M | Sell |
1,838,872
-632,678
| -26% | -$45M | 0.23% | 82 |
|
|
2020
Q1 | $155M | Buy |
2,471,550
+834,342
| +51% | +$60.2M | 0.44% | 38 |
|
|
2019
Q4 | $127M | Buy |
+1,637,208
| New | +$128M | 0.3% | 66 |
|
|
2019
Q3 | – | Sell |
-70,779
| Closed | -$4.36M | – | 1584 |
|
|
2019
Q2 | $4.36M | Sell |
70,779
-286,161
| -80% | -$17.3M | 0.01% | 680 |
|
|
2019
Q1 | $22.8M | Buy |
356,940
+278,025
| +352% | +$15.9M | 0.05% | 328 |
|
|
2018
Q4 | $4.03M | Sell |
78,915
-1,415,433
| -95% | -$71.6M | 0.01% | 625 |
|
|
2018
Q3 | $86.7M | Buy |
1,494,348
+199,767
| +15% | +$9.77M | 0.2% | 120 |
|
|
2018
Q2 | $62.8M | Buy |
1,294,581
+321,867
| +33% | +$15M | 0.15% | 151 |
|
|
2018
Q1 | $45.2M | Buy |
972,714
+630,318
| +184% | +$27.4M | 0.1% | 200 |
|
|
2017
Q4 | $12.9M | Sell |
342,396
-1,403,730
| -80% | -$51.5M | 0.03% | 400 |
|
|
2017
Q3 | $63.6M | Sell |
1,746,126
-694,044
| -28% | -$26.5M | 0.17% | 134 |
|
|
2017
Q2 | $96.2M | Buy |
2,440,170
+387,513
| +19% | +$14.1M | 0.29% | 97 |
|
|
2017
Q1 | $64.4M | Buy |
+2,052,657
| New | +$64.3M | 0.24% | 111 |
|
|
2016
Q4 | – | Sell |
-5,791,794
| Closed | -$233M | – | 1904 |
|
|
2016
Q3 | $233M | Buy |
5,791,794
+118,080
| +2% | +$4.45M | 0.76% | 23 |
|
|
2016
Q2 | $189M | Buy |
5,673,714
+2,984,991
| +111% | +$102M | 0.62% | 31 |
|
|
2016
Q1 | $79.1M | Buy |
2,688,723
+2,426,091
| +924% | +$66.9M | 0.33% | 69 |
|
|
2015
Q4 | $6.91M | Sell |
262,632
-1,967,238
| -88% | -$51.1M | 0.03% | 454 |
|
|
2015
Q3 | $52.8M | Sell |
2,229,870
-1,279,218
| -36% | -$30.9M | 0.25% | 91 |
|
|
2015
Q2 | $83.3M | Buy |
3,509,088
+651,288
| +23% | +$14.7M | 0.47% | 56 |
|
|
2015
Q1 | $67.9M | Buy |
2,857,800
+2,298,528
| +411% | +$51.6M | 0.42% | 61 |
|
|
2014
Q4 | $11.9M | Buy |
559,272
+445,266
| +391% | +$8.95M | 0.07% | 279 |
|
|
2014
Q3 | $1.94M | Buy |
+114,006
| New | +$1.8M | 0.01% | 593 |
|
|
2014
Q2 | – | Sell |
-349,224
| Closed | -$4.32M | – | 1032 |
|
|
2014
Q1 | $4.32M | Buy |
+349,224
| New | +$4.03M | 0.03% | 468 |
|
|
2013
Q4 | – | Sell |
-293,406
| Closed | -$3.4M | – | 1192 |
|
|
2013
Q3 | $3.4M | Sell |
293,406
-770,220
| -72% | -$9.01M | 0.02% | 446 |
|
|
2013
Q2 | $11.9M | Buy |
+1,063,626
| New | +$12.6M | 0.09% | 200 |
|
Other funds holding EW
VCM
VPM
Arrowstreet Capital's EW Position: Q1 2026 in Review
Arrowstreet Capital increased its Edwards Lifesciences (EW) stake by 341% in Q1 2026, buying an estimated $121M and bringing the position to 1,890,859 shares worth $151M. The position accounts for 0.08% of the portfolio, ranked #233.
Arrowstreet Capital first reported a position in EW in Q2 2013 and has held it in 48 quarters since. The position peaked at $422M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Arrowstreet Capital held 1,890,859 shares of Edwards Lifesciences worth $151M as of Q1 2026.
- Arrowstreet Capital bought 1,462,238 Edwards Lifesciences shares in Q1 2026, an estimated $121M.
- Edwards Lifesciences made up 0.08% of Arrowstreet Capital's portfolio in Q1 2026, its #233 holding.
- Arrowstreet Capital first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 48 quarters since.
- Arrowstreet Capital's Edwards Lifesciences position peaked at $422M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.